CCAM
VRTX icon

Codex Capital Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Codex Capital Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
3,370
+370
+12% +$164K 0.58% 29
2026
Q1 		$1.34M Sell
3,000
-4,320
-59% -$2.01M 0.52% 28
2025
Q4 		$3.32M Buy
7,320
+70
+1% +$30.2K 1.21% 22
2025
Q3 		$2.84M Sell
7,250
-4,500
-38% -$1.88M 1.07% 24
2025
Q2 		$5.23M Hold
11,750
– – 2.09% 18
2025
Q1 		$5.7M Hold
11,750
– – 2.68% 17
2024
Q4 		$4.73M Hold
11,750
– – 2.09% 21
2024
Q3 		$5.46M Hold
11,750
– – 2.42% 16
2024
Q2 		$5.51M Buy
+11,750
New +$5.1M 2.52% 17

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Codex Capital Asset Management's VRTX Position: Q2 2026 in Review

Codex Capital Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, buying an estimated $164K and bringing the position to 3,370 shares worth $1.67M. The position accounts for 0.58% of the portfolio, ranked #29.

Codex Capital Asset Management first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.7M in Q1 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Codex Capital Asset Management held 3,370 shares of Vertex Pharmaceuticals worth $1.67M as of Q2 2026.
  • Codex Capital Asset Management bought 370 Vertex Pharmaceuticals shares in Q2 2026, an estimated $164K.
  • Vertex Pharmaceuticals made up 0.58% of Codex Capital Asset Management's portfolio in Q2 2026, its #29 holding.
  • Codex Capital Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Codex Capital Asset Management's Vertex Pharmaceuticals position peaked at $5.7M in Q1 2025.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Codex Capital Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.